1-10 of 10
Gary Binder
Close
Sort by
Journal Articles

A Comparison of Acute Myeloid Leukemia (AML) Regimens: Hypomethylating Agents Combined with Ivosidenib or Venetoclax in Newly Diagnosed Patients with IDH1 Mutations: A Real-World Evidence Study

B. Douglas Smith, Curtis A Lachowiez, Alexander Joseph Ambinder, Gary Binder, Anne Angiolillo, Assaf Vestin, Robert Paglia, Ravi Potluri, Eros Papademetriou, Thomas W LeBlanc
Journal: Blood
Blood (2023) 142 (Supplement 1): 971.
https://doi.org/10.1182/blood-2023-173033
Published: 2023
Journal Articles

Early Treatment Initiation in Myelodysplastic Syndromes (MDS) Produces Higher Rate of and Earlier Transfusion Independence

Christopher R. Cogle, MD, Sheila R. Reddy, PhD RPh, Eunice Chang, PhD, Elya Papoyan, MPH, Michael S. Broder, MD MSHS, Michael McGuire, PharmD, Gary Binder, MBA
Journal: Blood
Blood (2016) 128 (22): 395.
https://doi.org/10.1182/blood.V128.22.395.395
Published: 2016
Journal Articles

Rationale for Therapy Discontinuation in Patients with Lower-Risk Transfusion-Dependent Myelodysplastic Syndromes (MDS)

Aaron T. Gerds, MD MS, Shaloo Gupta, MS, Gary Binder, MBA, Mikkael A. Sekeres, MD MS, Aziz Nazha, MD, Hetty E. Carraway, MD MBA, Stephanie Hawthorne, PhD, Kristen King-Concialdi, BS, Michael McGuire, PharmD
Journal: Blood
Blood (2016) 128 (22): 3541.
https://doi.org/10.1182/blood.V128.22.3541.3541
Published: 2016
Journal Articles

Relationship Between Lenalidomide Dose Modification and Outcomes in Patients with Myelodysplastic Syndromes

Amy E. DeZern, MD MHS, Gary Binder, Albert Fliss, PhD, X. Henry Hu, MD PhD, Syed Rizvi, MD, Frank A. Corvino, Steven R. Arikian, MD, Andy Surinach, Jianyi Lee, B. Douglas Smith, MD
Journal: Blood
Blood (2015) 126 (23): 3286.
https://doi.org/10.1182/blood.V126.23.3286.3286
Published: 2015
Journal Articles

Patterns of Total Costs of Care over Time for Patients with Multiple Myeloma (MM)

Steven R Arikian, Gary Binder, Craig Gibson, X Henry Hu, Yasir Nagarwala, Mohamad A. Hussein, Frank A. Corvino, Jianyi Lee, Andy Surinach, Satyin Kaura, Saad Usmani
Journal: Blood
Blood (2015) 126 (23): 3294.
https://doi.org/10.1182/blood.V126.23.3294.3294
Published: 2015
Journal Articles

Relationship Between Lenalidomide Dose Modification and Time to Next Treatment in Newly Diagnosed Multiple Myeloma Patients

Saad Z. Usmani, MD, Gary Binder, Dejan Milentijevic, X Henry Hu, Yasir Nagarwala, Frank A. Corvino, Steven R. Arikian, Andy Surinach, William N. Harwin
Journal: Blood
Blood (2014) 124 (21): 2655.
https://doi.org/10.1182/blood.V124.21.2655.2655
Published: 2014
Journal Articles

Patterns of Total Costs of Care for Newly Diagnosed Multiple Myeloma (MM) Patients

Steven R. Arikian, Dejan Milentijevic, Gary Binder, Mara Silvia Monzini, X Henry Hu, Yasir Nagarwala, Mohamad A. Hussein, MD, Frank A. Corvino, Andy Surinach, Saad Z. Usmani, MD
Journal: Blood
Blood (2014) 124 (21): 2656.
https://doi.org/10.1182/blood.V124.21.2656.2656
Published: 2014
Journal Articles

Components of Health Care Expenses Associated with Multiple Myeloma: An Analysis of US Claims Database

X Henry Hu, John Cai, Gary Binder, Mara Silvia Monzini, Yasir Nagarwala, MD
Journal: Blood
Blood (2014) 124 (21): 1318.
https://doi.org/10.1182/blood.V124.21.1318.1318
Published: 2014
Journal Articles

Relationship Between Lenalidomide Dose Modification and Duration Of Treatment In Newly Diagnosed Multiple Myeloma Patients

Kathy Lang, PhD, Gary Binder, MBA, Iris Lin, PhD, Dejan Milentijevic, PhD, Huan Huang, PhD, Yasir Nagarwala, MD, William N. Harwin, MD
Journal: Blood
Blood (2013) 122 (21): 2944.
https://doi.org/10.1182/blood.V122.21.2944.2944
Published: 2013
Journal Articles

Cost-Effectiveness Of Lenalidomide and Bortezomib In Patients With Previously Untreated Multiple Myeloma (MM)

Gerry Oster, PhD, Ariel Berger, MPH, Rebecca Bornheimer, BA, Gary Binder, MBA, Yasir Nagarwala, MD
Journal: Blood
Blood (2013) 122 (21): 5604.
https://doi.org/10.1182/blood.V122.21.5604.5604
Published: 2013